NAFDAC warns of suspected counterfeit asthma medication found in Nigerian market

NAFDAC has warned about suspected counterfeit asthma medication reportedly found in the Nigerian market. The product was identified in eastern Nigeria and traced to a distributor’s address in Anambra State. The warning concerns pharmaceutical-market compliance and public-health regulation, with relevance to Nigeria’s listed healthcare sector.